Replies to post #148727 on Cytodyn Inc (CYDY)

[justdafactss]

(sigh) More games that lead to nothing- Just like this PR---

“We are eager to reach conclusion in our discussions with all the regulatory agencies for the path going forward and will release the details of our data and the results of our discussions with regulatory agencies in the coming weeks.” Details of the Company’s ongoing discussions with the regulatory agencies are confidential.
https://www.globenewswire.com/news-release/2021/02/22/2179338/0/en/CytoDyn-in-Discussions-with-U-S-FDA-MHRA-and-Health-Canada-After-Unblinding-its-CD12-Trial-Data-for-Severe-to-Critically-Ill-COVID-19-Patients.html

[justdafactss]

7,122,185
Olson , et al. October 17, 2006
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=20&p=1&f=G&l=50&d=PTXT&S1=olson-william-c&OS=olson-william-c&RS=olson-william-c

Here's the patent number with 2 digits missing, you'll have to do some DD.
Sure it's a use patent???
LOL
US71**185B2

YES, it is a use patent---

Anti-CCR5 antibody

Abstract
The invention is directed an anti-CCR5 antibody which comprises (i) two light chains, each light chain comprising the expression product of a plasmid designated pVK:HuPRO140-VK (ATCC Deposit Designation PTA-4097), and (ii) two heavy chains, each heavy chain comprising an expression product of either a plasmid designated pVg4:HuPRO140 HG2-VH (ATCC Deposit Designation PTA-4098) or a plasmid designated pVg4:HuPRO140 (mutB+D+I)-VH (ATCC Deposit Designation PTA-4099) or a fragment thereof which binds to CCR5 on the surface of a human cell.